List of Chapters/Sections(Table Of Content)
1 Neuromodulation Devices and Implantable Infusion Pumps Market Overview
1.1 Product Overview and Scope of Neuromodulation Devices and Implantable Infusion Pumps
1.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Sacral Nerve Stimulation
1.2.5 Vagal Nerve Stimulation
1.2.6 Gastric Stimulation
1.2.7 Transcranial Magnetic Stimulation
1.2.8 Transcutaneous Electrical Stimulation
1.2.9 Other
1.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Comparison by Application: (2021-2027)
1.3.2 Parkinson's Disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Estimates and Forecasts
1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue 2016-2027
1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales 2016-2027
1.4.3 Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2016 Versus 2021 Versus 2027
2 Neuromodulation Devices and Implantable Infusion Pumps Market Competition by Manufacturers
2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2016-2021)
2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Sites, Area Served, Product Type
2.5 Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Situation and Trends
2.5.1 Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue
2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario by Region
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
3.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.4.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
3.4.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Region
3.5.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
3.5.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.6.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
3.6.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.7.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
3.7.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Analysis by Type
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2016-2021)
4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2016-2021)
5 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Analysis by Application
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2016-2021)
5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 St. Jude Medical
6.3.1 St. Jude Medical Corporation Information
6.3.2 St. Jude Medical Description and Business Overview
6.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.3.5 St. Jude Medical Recent Developments/Updates
6.4 Synapse Biomedical
6.4.1 Synapse Biomedical Corporation Information
6.4.2 Synapse Biomedical Description and Business Overview
6.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.4.5 Synapse Biomedical Recent Developments/Updates
6.5 Nevro Corporation
6.5.1 Nevro Corporation Corporation Information
6.5.2 Nevro Corporation Description and Business Overview
6.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.5.5 Nevro Corporation Recent Developments/Updates
6.6 Neuropace
6.6.1 Neuropace Corporation Information
6.6.2 Neuropace Description and Business Overview
6.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.6.5 Neuropace Recent Developments/Updates
6.7 Cyberonics
6.6.1 Cyberonics Corporation Information
6.6.2 Cyberonics Description and Business Overview
6.6.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.7.5 Cyberonics Recent Developments/Updates
6.8 Autonomic Technologies
6.8.1 Autonomic Technologies Corporation Information
6.8.2 Autonomic Technologies Description and Business Overview
6.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.8.5 Autonomic Technologies Recent Developments/Updates
6.9 Avery Biomedical
6.9.1 Avery Biomedical Corporation Information
6.9.2 Avery Biomedical Description and Business Overview
6.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.9.5 Avery Biomedical Recent Developments/Updates
6.10 Greatbatch Medical
6.10.1 Greatbatch Medical Corporation Information
6.10.2 Greatbatch Medical Description and Business Overview
6.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.10.5 Greatbatch Medical Recent Developments/Updates
7 Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Cost Analysis
7.1 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
7.4 Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors List
8.3 Neuromodulation Devices and Implantable Infusion Pumps Customers
9 Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics
9.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
9.2 Neuromodulation Devices and Implantable Infusion Pumps Growth Drivers
9.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
9.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
10 Global Market Forecast
10.1 Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Neuromodulation Devices and Implantable Infusion Pumps by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Neuromodulation Devices and Implantable Infusion Pumps by Type (2022-2027)
10.2 Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Neuromodulation Devices and Implantable Infusion Pumps by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Neuromodulation Devices and Implantable Infusion Pumps by Application (2022-2027)
10.3 Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Neuromodulation Devices and Implantable Infusion Pumps by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Neuromodulation Devices and Implantable Infusion Pumps by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
